Article
Proof of a 1-(3-chlorophenyl)piperazine (mCPP) intake: use as adulterant of cocaine resulting in drug-drug interactions?
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences - 15 Aug 2007
Staack Roland F, Paul Liane D, Schmid Dagmar, Roider Gabriele, Rolf Burkhard
Abstract excerpt
Since 2005, increasing numbers of seizures of the designer drug of abuse 1-(3-chlorophenyl)piperazine (mCPP) have been reported. This paper describes the unequivocal proof of a mCPP intake. Differentiation from the intake of its precursor drugs trazodone and nefazodone was performed by a systematic toxicological analysis (STA) procedure using full-scan GC-MS after acid hydrolysis, liquid-liquid extraction and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
